Valirx (VAL)

 

Latest News

Director Deals - ValiRx PLC (VAL)

Satu Vainikka, Chief Executive Officer, bought 400,000 shares in the company on the 15th March 2017 at a price of 2.50p. T...

Director Deals - ValiRx PLC (VAL)

Satu Vainikka, Chief Executive Officer, bought 400,000 shares in the company on the 15th March 2017 at a price of 2.50p. T...

Director Deals - ValiRx PLC (VAL)

Satu Vainikka, Chief Executive Officer, bought 400,000 shares in the company on the 15th March 2017 at a price of 2.50p. T...

Director/PDMR Shareholding

RNS Number: 5388Z ValiRx PLC 15 March 2017 ValiRx Plc ("ValiRx" or "the Company") PDMR / Director Dealing London, UK., 15 March 2017: ValiRx Plc (AIM: VAL), a clinical stage biotechnology company, announces that it has received the following notifications from PDMRs of dealings in the Company's shares, all of which related to the issue of shares annou...

All News

DateHeadlineSource
15-03-17Director Deals - ValiRx PLC (VAL)StockMarketWire
15-03-17Director Deals - ValiRx PLC (VAL)StockMarketWire
15-03-17Director Deals - ValiRx PLC (VAL)StockMarketWire
15-03-17Director/PDMR ShareholdingRNS
08-03-17ValiSeek Clinical Development UpdateRNS
08-03-17ValiRX - Projects updateBRR Media
02-03-17Director Deals - ValiRx PLC (VAL)StockMarketWire
02-03-17Director Deals - ValiRx PLC (VAL)StockMarketWire
02-03-17Director Deals - ValiRx PLC (VAL)StockMarketWire
02-03-17Director/PDMR ShareholdingRNS
01-03-17ValiRx raises £1.16m via placingStockMarketWire
01-03-17Placing to raise ?1.16m and Proposed SubscriptionRNS
28-02-17Publication of Peer-Reviewed Articles on VAL401RNS
11-01-17ValiRx notes positive VAL201 clinical trialStockMarketWire
11-01-17CLINICAL TRIAL UPDATE - Positive VAL201 ResultsRNS
30-12-16ValiRx notes Yorkville CLN conversionStockMarketWire
30-12-16Yorkville CLN ConversionRNS
08-12-16ValiRx says European patent granted for VAL201StockMarketWire
08-12-16European Patent Granted for Lead Compound VAL201RNS
02-12-16ValiRx loan draw downStockMarketWire
02-12-16Convertible Loan FacilityRNS
01-12-16ValiRx notes ValiSeek clinical development updateStockMarketWire
01-12-16ValiSeek Clinical Development UpdateRNS
01-12-16ValiRx Plc - ValiSeek Clinical Development UpdateBRR Media
29-11-16Quarterly Update on Clinical DevelopmentsRNS
03-11-16ValiSeek Clinical Development UpdateRNS
02-11-16ValiRx plc - Valiseek clinical development update BRR Media
28-10-16Corporate Video re Clinical Status Q4, 2016RNS
28-10-16ValiRX - Clinical Status Q4 2016BRR Media
25-10-16ValiRx issues patent updateStockMarketWire
25-10-16Patent UpdateRNS
13-10-16Holding(s) in CompanyRNS
13-10-16Holding(s) in CompanyRNS
13-10-16Update on Recent PresentationsRNS
12-10-16Result of General MeetingRNS
05-10-16CLN ConversionRNS
28-09-16Notice of GMRNS
27-09-16Half-year ReportRNS
27-09-16ValiRx - Half-year ReportBRR Media
26-09-16ValiRx selected for The Parliamentary Review 2016RNS

RSS feeds

  • Editorial news feed for LSE:VAL Editorial
  • Regulatory news feed for LSE:VAL Regulatory